Eric Schmidt, a commissioner on the federal National Security Commission on Emerging Biotechnology and formerly the CEO and Chairman of Google, wrote, "the next big game-changing revolution is in biology." He cited some milestones that were reached just last year: "The U.S. approved the production and sale of lab-grown meat for the first time; Google DeepMind's AI predicted structures of over 2 million new materials, which can potentially be used for chips and batteries; Casgevy became the first approved commercial gene-editing treatment using CRISPR."

Continue to the full article  |  More articles

Misguided COVID minimizers say COVID-19 is no worse than a cold that lasts a few days and disappears without a trace. They're so wrong, and the evidence of that continues to mount.

In 2022, the Centers for Disease Control and Prevention identified the onset of new conditions after infection that "might be related to their previous COVID-19 illness."

Continue to the full article  |  More articles

A breakthrough, almost decade-long study of a spray vaccine offers promise for hundreds of millions of women who suffer from urinary tract infections (UTIs) over their lifetimes.

The vaccine, called Uromune, was developed by Immunotek, a Spanish-based pharmaceutical company. It has been approved for use in two countries, the Dominican Republic and Mexico, and is under review for approval in Canada. It is also available under special-access conditions in 26 countries, but not the US.

Continue to the full article  |  More articles

From 1968 to 2020, Americans experienced a remarkable increase in life expectancy, from 70 to 78 years. Much of that was due to advances in drugs and vaccines, many of which are now unavailable because of shortages. According to the University of Utah Drug Information Service, in the first quarter of 2024, 323 drugs were in shortage — the highest number ever.

Shortages are vexing to practicing physicians and their patients. Dr. Deborah Greenhouse, a pediatrician in South Carolina, tweeted this:

Continue to the full article  |  More articles

The World Health Organization (WHO) on August 14 sounded the alarm about an mpox virus outbreak, declaring it a global health emergency for the second time in two years. While the initial outbreak in 2022 primarily affected gay and bisexual men, the current crisis is unfolding in a different, more alarming way.

Mpox (formerly known as monkeypox) is an infectious disease caused by the monkeypox virus. It can cause a painful rash, enlarged lymph nodes and fever. Most people fully recover, but some become gravely ill, and the infection can be fatal.

Continue to the full article  |  More articles